AVEO Oncology, EUSA Pharma announce updated interim results from phase II portion of the TiNivo study in renal cell carcinoma

Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era

Two lawsuits filed within days of each other in the U.S. District Court for the Northern District of Illinois claimed that Tempus AI Inc., an AI-driven precision and genomic testing company, had violated the Illinois Genetic Information Privacy Act when it acquired Ambry Genetics and started to integrate its genetics data into its predictive models.

March 04, 2026

Podcast The Directors

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

“We’ve always argued that money comes and goes, but if you lose a generation of scientists—you can’t buy them back,” said Kelvin Lee, director of the Indiana University Simon Comprehensive Cancer Center.

February 27, 2026

Vol.52 No.08

By Claire Marie Porter and Paul Goldberg

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable”

Two lawsuits filed within days of each other in the U.S. District Court for the Northern District of Illinois claim that Tempus AI Inc. had violated the Illinois Genetic Information Privacy Act when it acquired Ambry Genetics and started to integrate its genetics data into its predictive models.

February 27, 2026

Vol.52 No.08

By Paul Goldberg

Black History Month Podcast

Joni Nelson tells us how her background led her to pursue research that meets the needs of the community
“I’m standing on the shoulders of giants”

Joni D. Nelson, assistant director for the Office of Workforce Development at the MUSC Hollings Cancer Center, remembers the exact day a switch went off in her head and her career took a turn towards finding ways to improve public health.

February 27, 2026

Vol.52 No.08

By Joni D. Nelson, Robert A. Winn and Preston Willett

After a year, Stephenson institute sees a broader role in funding pancreatic cancer research, fostering collaborations
“We are not just funding research. We are building a trusted community.”

The Stephenson Global Pancreatic Cancer Research Institute, established a little over a year ago with a $150 million gift from entrepreneurs and philanthropists A. Emmet Stephenson Jr. and Tessa Stephenson Brand, has refined its goals.

When radiology fails to fix clinical trial imaging workflow at sites…
What most think, why it’s wrong, and what cancer centers really need

Radiology departments have tried for years to “own” or “fix” clinical trials imaging assessment workflows by extending clinical tools (PACS, worklists, dictation systems) and habits (speed, seamlessness, few clicks) into the research world.

February 27, 2026

Vol.52 No.08

By Jeff Sorenson

AVEO Oncology, EUSA Pharma announce updated interim results from phase II portion of the TiNivo study in renal cell carcinoma

YOU MAY BE INTERESTED IN

Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable”

Joni Nelson tells us how her background led her to pursue research that meets the needs of the community
“I’m standing on the shoulders of giants”

After a year, Stephenson institute sees a broader role in funding pancreatic cancer research, fostering collaborations
“We are not just funding research. We are building a trusted community.”

When radiology fails to fix clinical trial imaging workflow at sites…
What most think, why it’s wrong, and what cancer centers really need

Renew today!

Subscriber content

Never miss an issue!

Login

AVEO Oncology, EUSA Pharma announce updated interim results from phase II portion of the TiNivo study in renal cell carcinoma

YOU MAY BE INTERESTED IN

Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE“Deidentified” ≠ “deidentifiable”

Joni Nelson tells us how her background led her to pursue research that meets the needs of the community“I’m standing on the shoulders of giants”

After a year, Stephenson institute sees a broader role in funding pancreatic cancer research, fostering collaborations“We are not just funding research. We are building a trusted community.”

When radiology fails to fix clinical trial imaging workflow at sites…What most think, why it’s wrong, and what cancer centers really need

Never miss an issue!

Login

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable”

Joni Nelson tells us how her background led her to pursue research that meets the needs of the community
“I’m standing on the shoulders of giants”

After a year, Stephenson institute sees a broader role in funding pancreatic cancer research, fostering collaborations
“We are not just funding research. We are building a trusted community.”

When radiology fails to fix clinical trial imaging workflow at sites…
What most think, why it’s wrong, and what cancer centers really need